Evidence map›Paper›PMID 16142674›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2005

Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.

Thanyawee Puthanakit, Penninah Oberdorfer, Suchart Punjaisee, Pornphun Wannarit, Thira Sirisanthana, Virat Sirisanthana

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2011
    Trial
  4. Article
  5. Review
  6. BCG: a vaccine with multiple faces.Human vaccines & immunotherapeutics · 2020
    Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. BCG Vaccination in HIV-Infected Children.Tuberculosis research and treatment · 2011
    Article
  14. Article
  15. Article
  16. BCG vaccination in South African HIV-exposed infants--risks and benefits.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 2009
    Article
  17. Pediatric HIV immune reconstitution inflammatory syndrome.Current opinion in HIV and AIDS · 2008
    Article
  18. Review
  19. Article
  20. Vaccination in patients with HIV infection.Current infectious disease reports · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thanyawee PuthanakitFaculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Penninah Oberdorfer
Suchart Punjaisee
Pornphun Wannarit
Thira Sirisanthana
Virat Sirisanthana
Chiang Mai University · THMinistry of Public Health · TH

Funding

Effect of the HIV epidemic on children in ThailandR01TW006187 · FIC · CHIANG MAI UNIVERSITY · PI PUTHANAKIT, THANYAWEE · 2002 to 2006
$269k
FIC NIH HHS 5R01TW006187-03FIC NIH HHS R01 TW006187FIC NIH HHS R01 TW006187-03
6 · The paper itself

Abstract

The immune reconstitution syndrome caused by bacillus Calmette-Guerin (BCG) was found in 4 HIV-infected children who were immunized with BCG at birth. The localized, suppurative, BCG-related complications developed within 10 weeks after initiation of antiretroviral therapy. The incidence rate was 2.7 cases per 100 persons (95% confidence interval, 0.7-6.7). Patients responded well to treatment with isoniazid and rifampicin.

Indexed as

Anti-HIV AgentsAntitubercular AgentsBCG VaccineChildFemaleHIV InfectionsHumansInfantIsoniazidRifampinTuberculosis, Lymph NodeAnti-HIV AgentsAntitubercular AgentsBCG VaccineIsoniazidRifampin

Identifiers

PMID16142674
PMCPMC1924528
OpenAlexW2128754471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.